Cargando…

Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors

Reprogramming of metabolic priorities promotes tumor progression. Our understanding of the Warburg effect, based on studies of cultured cancer cells, has evolved to a more complex understanding of tumor metabolism within an ecosystem that provides and catabolizes diverse nutrients provided by the lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patra, Sayani, Elahi, Naveed, Armorer, Aaron, Arunachalam, Swathi, Omala, Joshua, Hamid, Iman, Ashton, Anthony W., Joyce, David, Jiao, Xuanmao, Pestell, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495201/ https://www.ncbi.nlm.nih.gov/pubmed/34631530 http://dx.doi.org/10.3389/fonc.2021.700629

Ejemplares similares

The Role and Therapeutic Targeting of CCR5 in Breast Cancer
por: Hamid, Rasha, et al.
Publicado: (2023)

An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5
por: Lah Turnšek, Tamara, et al.
Publicado: (2021)

Mitochondrial mass and DNA repair in breast cancer stem cells
por: Pestell, Richard G., et al.
Publicado: (2015)

The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance
por: Abdelmalak, Mary, et al.
Publicado: (2022)

Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
por: Jiao, Xuanmao, et al.
Publicado: (2021)

The membrane-associated form of cyclin D1 enhances cellular invasion
por: Chen, Ke, et al.
Publicado: (2020)

Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology
por: Di Sante, Gabriele, et al.
Publicado: (2019)

Small Non-coding RNAs Govern Mammary Gland Tumorigenesis
por: Yu, Zuoren, et al.
Publicado: (2012)

Heterogeneity Analysis of Bladder Cancer Based on DNA Methylation Molecular Profiling
por: Wang, Shuyu, et al.
Publicado: (2022)

Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
por: Jiao, Xuanmao, et al.
Publicado: (2021)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Reversible Adaptive Plasticity: A Mechanism for Neuroblastoma Cell Heterogeneity and Chemo-Resistance
por: Chakrabarti, Lina, et al.
Publicado: (2012)

Multiple Myeloma Presenting as Acute Renal Failure in the Absence of Other Characteristic Features
por: Gastelum, Zachary N, et al.
Publicado: (2017)

GATA1 Activity Governed by Configurations of cis-Acting Elements
por: Hasegawa, Atsushi, et al.
Publicado: (2017)

Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs
por: Bhattacharjee, Rahul, et al.
Publicado: (2022)

Autophagic Heterogeneity in Gastric Adenocarcinoma
por: Yoon, Ju-Yoon, et al.
Publicado: (2021)

Inducible transgenics. New lessons on events governing the induction and commitment in mammary tumorigenesis
por: Hulit, James, et al.
Publicado: (2001)

The emerging role of miR-20b in human cancer and other disorders: Pathophysiology and therapeutic implications
por: Khalilian, Sheyda, et al.
Publicado: (2022)

Emerging Understanding of Multiscale Tumor Heterogeneity
por: Gerdes, Michael J., et al.
Publicado: (2014)

Measuring Intratumoral Heterogeneity of Immune Repertoires
por: Yuzhakova, Diana Vladimirovna, et al.
Publicado: (2020)

Intratumor Heterogeneity in Early Lung Adenocarcinoma
por: Senosain, Maria-Fernanda, et al.
Publicado: (2020)

Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
por: Wu, Xiaoxuan, et al.
Publicado: (2022)

Interventions designed to increase the uptake of lung cancer screening and implications for priority populations: a scoping review protocol
por: Sayani, Ambreen, et al.
Publicado: (2021)

Evaluating Heterogeneity of Primary Lung Tumor Using Clinical Routine Magnetic Resonance Imaging and a Tumor Heterogeneity Index
por: Hu, Nan, et al.
Publicado: (2021)

The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma
por: Pletcher, Jerred P., et al.
Publicado: (2021)

Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications
por: Parker, Nicole Renee, et al.
Publicado: (2015)

Management of the Axilla in the Era of Breast Cancer Heterogeneity
por: de Meric de Bellefon, Maïlys, et al.
Publicado: (2018)

Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer
por: Morozov, Alexey V., et al.
Publicado: (2019)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Endogenous Cyclin D1 Promotes the Rate of Onset and Magnitude of Mitogenic Signaling via Akt1 Ser473 Phosphorylation
por: Chen, Ke, et al.
Publicado: (2020)

Metastasis: Other Side of the Coin
por: Ahmad, Aftab, et al.
Publicado: (2015)

Environmental Governance Goals of Local Governments and Technological Innovation of Enterprises under Green Performance Assessment
por: Wang, Xingshuai, et al.
Publicado: (2023)

Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer
por: Pereira, Lloyd, et al.
Publicado: (2015)

Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
por: Juiz, Natalia Anahi, et al.
Publicado: (2019)

Brain Microenvironment Heterogeneity: Potential Value for Brain Tumors
por: Álvaro-Espinosa, Laura, et al.
Publicado: (2021)

Visualising spatial heterogeneity in glioblastoma using imaging habitats
por: Waqar, Mueez, et al.
Publicado: (2022)

Evolution of Voltage-Dependent Anion Channel Function: From Molecular Sieve to Governator to Actuator of Ferroptosis
por: Lemasters, John J.
Publicado: (2017)

Temporal and Spatial Differentiations in Environmental Governance
por: Peng, Benhong, et al.
Publicado: (2018)

Hormonal Receptor Immunochemistry Heterogeneity and (18)F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast Cancers
por: Aide, Nicolas, et al.
Publicado: (2021)

Optimal Environmental Policy for Heterogeneous Governments in China
por: Wang, Ren, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rcsnr8jo68d853jgqd4td79qq3